Cargando…

Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors

Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) tyrosine kinase inhibitors (TKIs) have achieved remarkable clinical progress in the treatment of non-small-cell lung cancer; however, resistance has limited their therapeutic efficacy. Therefore, understanding the mechanisms of VEGF-TKI and ICI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yingzhuo, Wang, Jian, Wang, Xu, Zhou, Xiaoshu, Tang, Jing, Jie, Xiaohua, Yang, Xijie, Rao, Xinrui, Xu, Yunhong, Xing, Biyuan, Li, Zhenyu, Wu, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786837/ https://www.ncbi.nlm.nih.gov/pubmed/35075132 http://dx.doi.org/10.1038/s41420-022-00818-8

Ejemplares similares

REV1 promotes lung tumorigenesis by activating the Rad18/SERTAD2 axis
por: Chen, Yunshang, et al.
Publicado: (2022)

PD-1(+) mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy
por: Li, Jun, et al.
Publicado: (2022)

NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer
por: Rao, Xinrui, et al.
Publicado: (2022)

Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer
por: Zhou, Xiaoshu, et al.
Publicado: (2022)

Nuclear localization of the tyrosine kinase BMX mediates VEGFR2 expression
por: Liu, Tingting, et al.
Publicado: (2019)

Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
por: Steeghs, Neeltje, et al.
Publicado: (2009)

Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models
por: Dev, I K, et al.
Publicado: (2004)

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
por: Amano, Hideki, et al.
Publicado: (2021)

Targeting polymerase θ impairs tumorigenesis and enhances radiosensitivity in lung adenocarcinoma
por: Rao, Xinrui, et al.
Publicado: (2023)

Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
por: Hsu, Jeff, et al.
Publicado: (2023)

ADRB2-Targeting Therapies for Prostate Cancer
por: Kulik, George
Publicado: (2019)

Development of Second-Generation VEGFR Tyrosine Kinase Inhibitors: Current Status
por: Bhargava, Pankaj, et al.
Publicado: (2011)

MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma
por: Kinget, Lisa, et al.
Publicado: (2021)

Genetic Polymorphisms in ADRB2 and ADRB1 Are Associated with Differential Survival in Heart Failure Patients Taking β-Blockers
por: Guerra, Leonardo A., et al.
Publicado: (2022)

BRD4‐IRF1 axis regulates chemoradiotherapy‐induced PD‐L1 expression and immune evasion in non‐small cell lung cancer
por: Wang, Jian, et al.
Publicado: (2022)

Expression of ADRB2 in children with neuroblastoma and its influence on prognosis
por: Cao, Lijian, et al.
Publicado: (2022)

Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
por: Xu, Shanrong, et al.
Publicado: (2023)

Association of ADRB2 polymorphism with triglyceride levels in Tongans
por: Naka, Izumi, et al.
Publicado: (2013)

ZD6474 – a novel inhibitor of VEGFR and EGFR tyrosine kinase activity
por: Ryan, A J, et al.
Publicado: (2005)

Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2
por: Zhang, Xuan, et al.
Publicado: (2019)

Obesity-related gene ADRB2, ADRB3 and GHRL polymorphisms and the response to a weight loss diet intervention in adult women
por: Saliba, Louise F., et al.
Publicado: (2014)

Investigating changes in β-adrenergic gene expression (ADRB1 and ADRB2) in Takotsubo (stress) cardiomyopathy syndrome; a pilot study
por: Tutgun Onrat, Serap, et al.
Publicado: (2021)

The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase
por: Pierotti, Catia L., et al.
Publicado: (2023)

ADRB2 expression predicts the clinical outcomes and is associated with immune cells infiltration in lung adenocarcinoma
por: Ji, Lingyun, et al.
Publicado: (2022)

Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury
por: Rao, Xinrui, et al.
Publicado: (2023)

Correction to: Investigating changes in β‑adrenergic gene expression (ADRB1 and ADRB2) in Takotsubo (stress) cardiomyopathy syndrome; a pilot study
por: Onrat, Serap Tutgun, et al.
Publicado: (2022)

ADRB2 polymorphisms predict the risk of myocardial infarction and coronary artery disease
por: Wang, Dong-Wei, et al.
Publicado: (2015)

Endosome-to-Plasma Membrane Recycling of VEGFR2 Receptor Tyrosine Kinase Regulates Endothelial Function and Blood Vessel Formation
por: Jopling, Helen M., et al.
Publicado: (2014)

Human-Specific SNP in Obesity Genes, Adrenergic Receptor Beta2 (ADRB2), Beta3 (ADRB3), and PPAR γ2 (PPARG), during Primate Evolution
por: Takenaka, Akiko, et al.
Publicado: (2012)

Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles
por: Abdel-Mohsen, Heba T., et al.
Publicado: (2020)

Transcription Factor E2F1 Regulates the Expression of ADRB2
por: Du, Juan, et al.
Publicado: (2023)

Blockade of VEGFR-1 and VEGFR-2 Enhances Paclitaxel Sensitivity in Gastric Cancer Cells
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
por: Jiang, Zongru, et al.
Publicado: (2020)

A functional SNP upstream of the ADRB2 gene is associated with COPD
por: Li, Jin-Xiu, et al.
Publicado: (2018)

ADRB2 Gene Polymorphisms and Salbutamol Responsiveness in Serbian Children with Asthma
por: Jovicic, N, et al.
Publicado: (2018)

ADRB3, ROCK2, and GEF Levels in Overactive Bladder Patients
por: Fırat, Elif, et al.
Publicado: (2022)

Photoactivatable Caged Prodrugs of VEGFR-2 Kinase Inhibitors
por: Pinchuk, Boris, et al.
Publicado: (2016)

Activation of ADRB2/PKA Signaling Pathway Facilitates Lipid Synthesis in Meibocytes, and Beta-Blocker Glaucoma Drug Impedes PKA-Induced Lipid Synthesis by Inhibiting ADRB2
por: Jun, Ikhyun, et al.
Publicado: (2022)

Ligand-Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamic Studies of Dual Tyrosine Kinase Inhibitor of EGFR and VEGFR2
por: Sangande, Frangky, et al.
Publicado: (2020)

Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence
por: Chu, Xun, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0f7461hb23d6u8bf6lthvq65k1